The Role of HPV Clearance and Cancer Prevention Therapy in Cervical Cancer
NQ Score
87/100
N1 Content Completeness
9
AI Summary (NQ-processed)
Namihira Ladies Clinic has announced significant results from its 37-year research on HPV clearance using the SIR-Method, achieving an 84.6% HPV clearance rate and 98.7% cytological normalization. This sustainable, fertility-preserving approach offers a promising alternative to conventional surgical treatments for cervical precancerous lesions.
AI Analysis
Frequently Asked Questions
- Q: What is HPV?
- A: Human papillomavirus (HPV) is the primary cause of cervical cancer and is transmitted through sexual contact.
- Q: What is the SIR-Method?
- A: A conservative therapy that scrapes infected tissue to induce antigen exposure and local inflammation for HPV clearance.
- Q: How effective is this treatment?
- A: It achieved an 84.6% HPV clearance rate, with 98.7% of abnormal Pap smears returning to normal.
- Q: Does it affect fertility?
- A: Unlike traditional surgery, this non-surgical approach preserves fertility.
- Q: Where can I receive this treatment?
- A: Available at Namihira Ladies Clinic in Setagaya, Tokyo, with international patents secured.